Maintenance therapy improves the survival outcomes of patients with metastatic nasopharyngeal carcinoma responding to first-line chemotherapy: a multicentre, randomized controlled clinical study

被引:0
|
作者
Ying Lu
Haixin Huang
Hui Yang
Xiaohua Hu
Meilian Liu
Changjie Huang
Xianbin Feng
Xishan Chen
Zhou Jiang
机构
[1] The Fourth Affiliated Hospital of Guangxi Medical University,Department of Oncology
[2] The First Affiliated Hospital of Guangxi Medical University,Department of Oncology
[3] Affiliated Hospital of Guilin Medical College,Department of Oncology
[4] The Third Affiliated Hospital of Guangxi Medical University,Department of Oncology
[5] Liuzhou Hospital of Traditional Chinese Medicine,Department of Oncology
关键词
Nasopharyngeal carcinoma; Tegafur/gimeracil/oteracil; Maintenance therapy; Epstein‒Barr virus-DNA; Human serum amyloid A;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4327 / 4338
页数:11
相关论文
共 50 条
  • [1] Maintenance therapy improves the survival outcomes of patients with metastatic nasopharyngeal carcinoma responding to first-line chemotherapy: a multicentre, randomized controlled clinical study
    Lu, Ying
    Huang, Haixin
    Yang, Hui
    Hu, Xiaohua
    Liu, Meilian
    Huang, Changjie
    Feng, Xianbin
    Chen, Xishan
    Jiang, Zhou
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 4327 - 4338
  • [2] Maintenance Intervention Improves Survival in Patients With Metastatic Nasopharyngeal Carcinoma Who Benefit From First-Line Treatment: A Prospective Multicenter Randomized Controlled Clinical Study
    Lu, Y.
    Huang, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E386 - E386
  • [3] Maintenance intervention to improve survival in patients with metastatic nasopharyngeal carcinoma who benefit from first-line treatment: A prospective multicenter randomized controlled clinical study.
    Lu, Ying
    Huang, Haixin
    Yang, Hui
    Hu, Xiaohua
    Feng, Xianbing
    Huang, Changjie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma
    Chua, DTT
    Sham, JST
    Au, GKH
    ORAL ONCOLOGY, 2005, 41 (06) : 589 - 595
  • [5] Gemcitabine Plus Platinum versus Docetaxel Plus Platinum as First-Line Therapy for Metastatic Nasopharyngeal Carcinoma: A Randomized Clinical Study
    Yang, Hui
    Lu, Ying
    Xu, Zhuohua
    Wei, Mingjing
    Huang, Haixin
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2021, 9 (02): : 125 - 134
  • [6] Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma
    Li, Yu-Hong
    Wang, Feng-Hua
    Jiang, Wen-Qi
    Xiang, Xiao-Juan
    Deng, Yan-Ming
    Hu, Guo-Qing
    Xu, De-Ming
    Chen, Yan
    Lin, Qing
    He, You-Jian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) : 539 - 544
  • [7] Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma
    Yu-Hong Li
    Feng-Hua Wang
    Wen-Qi Jiang
    Xiao-Juan Xiang
    Yan-Ming Deng
    Guo-Qing Hu
    De-Ming Xu
    Yan Chen
    Qing Lin
    You-Jian He
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 539 - 544
  • [8] Capecitabine Maintenance Therapy after First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer
    Yan Li
    Department of GI Oncology
    Chinese Journal of Cancer Research, 2010, 22 (03) : 181 - 185
  • [9] Capecitabine Maintenance Therapy after First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer
    Li, Yan
    Li, Jing
    Lu, Ming
    Wang, Xi-cheng
    Shen, Lin
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (03) : 181 - 185
  • [10] Gemcitabine maintenance versus observation after first-line chemotherapy in patients with metastatic urothelial carcinoma: a retrospective study
    Kim, Hyunho
    Lee, Seung-Hwan
    Kim, Dong Hwan
    Lee, Ji Youl
    Hong, Sung-Hoo
    Ha, U-Syn
    Kim, In-Ho
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (05) : 2113 - 2121